Comparative Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Malaria in Ugandan Children.

Yeka, Adoke; Wallender, Erika; Mulebeke, Ronald; Kibuuka, Afizi; Kigozi, Ruth; Bosco, Agaba; Kyambadde, Paul; Opigo, Jimmy; Kalyesubula, Simeon; Senzoga, Joseph; Vinden, Joanna; Conrad, Melissa; Rosenthal, Philip J

Yeka, Adoke; Wallender, Erika; Mulebeke, Ronald; Kibuuka, Afizi; Kigozi, Ruth; Bosco, Agaba; Kyambadde, Paul; Opigo, Jimmy; Kalyesubula, Simeon; Senzoga, Joseph; Vinden, Joanna; Conrad, Melissa; Rosenthal, Philip J.

Afiliación

Yeka A; School of Public Health, Makerere University College of Health Sciences.
Wallender E; Department of Medicine, University of California, San Francisco.
Mulebeke R; School of Public Health, Makerere University College of Health Sciences.
Kibuuka A; School of Public Health, Makerere University College of Health Sciences.
Kigozi R; Malaria Action Programme for Districts, Malaria Consortium.
Bosco A; National Malaria Control Program, Ministry of Health, Uganda.
Kyambadde P; National Malaria Control Program, Ministry of Health, Uganda.
Opigo J; National Malaria Control Program, Ministry of Health, Uganda.
Kalyesubula S; East African Public Health Laboratories Networking Project, Kampala, Uganda.
Senzoga J; East African Public Health Laboratories Networking Project, Kampala, Uganda.
Vinden J; School of Public Health, University of California, Berkeley.
Conrad M; Department of Medicine, University of California, San Francisco.
Rosenthal PJ; Department of Medicine, University of California, San Francisco.

J Infect Dis ; 219(7): 1112-1120, 2019 03 15.

Article en En | MEDLINE | ID: mdl-30418593

Asunto(s)

Antimaláricos/uso terapéutico; Combinación Arteméter y Lumefantrina/uso terapéutico; Artemisininas/uso terapéutico; Malaria Falciparum/tratamiento farmacológico; Parasitemia/tratamiento farmacológico; Quinolinas/uso terapéutico; Antimaláricos/efectos adversos; Combinación Arteméter y Lumefantrina/efectos adversos; Artemisininas/efectos adversos; Preescolar; Investigación sobre la Eficacia Comparativa; Combinación de Medicamentos; Resistencia a Medicamentos/genética; Femenino; Genotipo; Humanos; Lactante; Masculino; Proteínas de Transporte de Membrana/genética; Proteínas Asociadas a Resistencia a Múltiples Medicamentos/genética; Parasitemia/parasitología; Plasmodium falciparum/genética; Proteínas Protozoarias/genética; Quinolinas/efectos adversos; Recurrencia; Método Simple Ciego; Uganda

Palabras clave

Treatment efficacy; Uganda; artemether-lumefantrine; dihydroartemisinin-piperaquine; malaria

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Quinolinas / Malaria Falciparum / Parasitemia / Artemisininas / Combinación Arteméter y Lumefantrina / Antimaláricos Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Child, preschool / Female / Humans / Infant / Male País/Región como asunto: Africa Idioma: En Revista: J Infect Dis Año: 2019 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google